QLB Biotherapeutics

Biotechnology Research • Boston, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	Boston, Massachusetts, United States
Website	qlb-bio.com
SIC	283
Employees	1-10

Key Contact at QLB Biotherapeutics

Langzhou Song

Senior Director, Antibody Discovery, Engineering and Function

About QLB Biotherapeutics

QLB Biotherapeutics Inc., located in Boston, Massachusetts, is a startup biotechnology company focusing on discovering and developing biological therapeutics. QLB Bio is funded by Qilu Pharmaceutical, and will become its biggest overseas Research and Development Center. QLB Bio is devoted to developing next-generation cancer therapeutics using the transformative potential of immunotherapy. We have an ambitious vision and a growing pipeline of novel cancer immunotherapy biological candidates to treat solid tumors as well as hematologic cancers. To achieve our mission, we seek highly motivated professionals who share our dedication to patients and our passion for discovery, innovation and scientific rigor.

QLB Biotherapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Employees by Department

QLB Biotherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

QLB Biotherapeutics has never raised funding before.

Frequently asked questions

QLB Biotherapeutics is located in Boston, Massachusetts, US.

QLB Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at QLB Biotherapeutics

Langzhou Song

Senior Director, Antibody Discovery, Engineering and Function

4.8

40,000 users